Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Nanosonics Limited ( (AU:NAN) ) has provided an update.
Nanosonics Limited has announced an update regarding its ongoing on-market buy-back program. As of December 9, 2025, the company has repurchased a total of 355,909 ordinary fully paid securities, with an additional 51,000 securities bought back on the previous day. This buy-back initiative is part of the company’s strategy to manage its capital structure and potentially enhance shareholder value.
The most recent analyst rating on (AU:NAN) stock is a Buy with a A$5.43 price target. To see the full list of analyst forecasts on Nanosonics Limited stock, see the AU:NAN Stock Forecast page.
More about Nanosonics Limited
Nanosonics Limited operates in the healthcare industry, specializing in infection prevention solutions. The company is known for its innovative products that focus on reducing the risk of infection transmission, primarily through its trophon® technology, which is used for high-level disinfection of ultrasound probes.
Average Trading Volume: 607,884
Technical Sentiment Signal: Hold
Current Market Cap: A$1.27B
For detailed information about NAN stock, go to TipRanks’ Stock Analysis page.